Introduction
Paraherquamide (PHQ, Figure 1 ) is an oxindole alkaloid anthelmintic that was originally isolated from cultures of Penicillium paraherquei (Yamazaki, et al., 1981) . Its potent antiparasitic activity was first discovered in a rodent model (Ostlind, et al., 1990) in which gerbils were infected with immature Trichostrongylus colubriformis. PHQ was found to be effective orally at 1.5 mg/kg and well tolerated at doses up to 200 mg/kg. Subsequent studies in our laboratories revealed that PHQ has broad spectrum nematodicidal activity in sheep and a single 0.5 mg/kg oral dose was effective against 6 common nematodes from the ovine gastrointestinal tract, including an ivermectinresistant strain of Haemonchus contortus, a parasite known to cause significant losses in affected flocks (Shoop, et al., 1990; Sargison, et al., 2001) . Only Oesophagostomum columbianum, a parasite residing in the lower bowel, showed some resistance and required doses above 4 mg/kg for efficacy. No adverse effects were observed in sheep at oral doses up to 20 mg/kg. PHQ was likewise effective and well tolerated in calves (Shoop, et al., 1992b) .
In dogs, however, PHQ was not only inactive against most of the nematode species examined but produced adverse effects within 1 h of treatment that included depression, ataxia, and protrusion of the nictitating membrane at doses ranging from 0.5 to 2 mg/kg (Shoop, et al., 1991) . These adverse effects were only marginally reversible over 7 days and in subsequent studies in our laboratories, were also accompanied by occasional deaths (Shoop, et al., 1992a) . More recent studies have shown that PHQ is an antagonist of nicotinic cholinergic receptors in nematodes and mammals (Zinser, et al., 2002; Robertson, et al., 2002) and suggest that PHQ exerts its nematodicidal action by inducing nematode paralysis through blockade of cholinergic neuromuscular This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on May 27, 2008 as DOI: 10.1124 at ASPET Journals on November 6, 2017 dmd.aspetjournals.org Downloaded from transmission.
The adverse effects observed in dogs may result from the same mechanism.
The notable difference in PHQ's pharmacological and toxicological effects in sheep and gerbils, where it is effective and safe, and that in dogs, where it is largely ineffective and toxic, is intriguing. The underlying cause for such differences is likely to be multifactorial and may involve differences in PHQ's affinity to cholinergic receptors in these species as well as species-specific pharmacokinetics and/or metabolism. The objectives of the present studies were to compare the pharmacokinetics and metabolism of PHQ in sheep, gerbils and dogs.
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Materials and Method
Chemicals: Paraherquamide (PHQ) was isolated as previously described (Yamazaki, et al., 1981) 
and [5-3 H]PHQ was prepared by the Merck Labeled Compound
Synthesis Group (Rahway, NJ) (Blizzard, et al., 1990) . All other chemicals were of the highest analytical purity available.
In vitro metabolism: Liver microsomes were prepared according to a standard protocol (Raucy and Lasker, 1991) . [ 3 H]PHQ (10 µM) was incubated with liver microsomes (2 mg/ml) at 37 o C for 60 min in 100 mM phosphate buffer containing 5 mM MgCl 2 and 1 mM NADPH in total incubation volume of 2 mL. Disappearance of the parent was monitored by taking 50 µL aliquots and quenching the reaction with 100
µL acetonitrile containing an internal standard. After protein removal by centrifugation, samples were analyzed as described in the pharmacokinetic section (see below). After 60 min, the remainder of the reaction mixture was treated using 2 volumes of acetonitrile, . For NMR analysis of the metabolites produced from sheep liver microsomes, the reaction volume was increased to 100 ml and products extracted by solid phase extraction using a 12 ml OASIS HLB cartridge (Waters, Milford, MA) eluted with acetonitrile. Isolation of the metabolites was performed by semi-preparative HPLC (see below). In vitro activity against Haemonchus contortus. Activity against H. contortus was performed using a larval development assay (LDA) based on a previously published technique (Hubert and Kerboeuf, 1992) . In the LDA, embryonation, hatching, feeding and molting to the L3 development stage occurred in constant contact with the test compounds during a 5 day period. Larval motility was assessed using a digital camera and a computerized pixel reader. , 0.25, 0.5, 1, 2, 4, 6, 8, 12 (sheep only), 24, 48 , and 72 h and plasma was obtained by centrifugation at 3,000 rpm for 10 min at 4 o C. Urine and feces were collected in 24-h intervals. For sheep, a total of 4 animals were used and one sheep was euthanized every 24 h. The entire GI-tract was divided by sections and the contents collected and homogenized. A sample of bile was also collected at each time point.
Excretion and metabolism studies in gerbils were performed after a single oral dose of of PHQ has been published elsewhere (Blanchflower, et al., 1991; Liesch and Wichmann, 1990 ) and only the chemical shifts of the H12-17 protons are given here (Table 2) Co-eluting metabolites M4 and M5 were formed in a 3:1 mixture (by 1 H NMR, data not shown) and were the major metabolites identified in gerbil liver microsomes.
M4 had a protonated molecular ions at m/z 506 and product ions at m/z 488, 431 and 403, corresponding to the subsequent neutral losses of H 2 O, CH 3 NCO and CO (Table 1 ).
The loss of CO suggested the presence of a carbonyl group. The 1 H NMR spectrum of M4 was characterized by the absence of the methylene signals at position 15 and 16 that were replaced by a single vinylic signal at δ = 6.08 ppm. The original methyl group at position 17 was replaced with a methylene group that was shifted ~3 ppm down field (Table 2) . Taken together these data indicated that M4 arose from successive oxidation at C14 to a carbonyl group, dehydration and hydroxylation at C17 (Figure 4 ). In vitro activity of against H contortus. The major metabolites of PHQ identified in sheep liver microsomes were isolated and tested for nematodicidal activity against H.
contortus at 1 µg/ml. At that concentration, PHQ causes an 80 % decrease in the motility of H. contortus larvae. None of the metabolites tested were significantly more active than PHQ ( Figure 5 ). However, M4 showed a significantly reduced activity.
Prior testing in our laboratories indicated that M1, the major metabolite identified in dog liver microsomes was pharmacologically inactive against nematodes. M5 could not be isolated in sufficient amounts and its activity against H. contortus was not tested, however it was inactive against T. colubriformis in vivo (Blanchflower, et al., 1991; Liesch and Wichmann, 1990) .
Pharmacokinetics. The oral pharmacokinetics of PHQ and total drug related material (DRM) were evaluated in sheep and dogs after a single 0.5 mg/kg dose of
The absorption of PHQ was rapid in both species and maximum plasma concentration was reached at a t max of 0.5 h with C max of 38 and 73 ng/mL in sheep and dogs, respectively ( Figure 6 ). In sheep, the plasma concentration of PHQ reached a second concentration maximum of 40 ng/mL at 2 h post-dose which might be due to rumination. The apparent plasma elimination t 1/2 of PHQ in sheep was ~ 8.5 h whereas the apparent t 1/2 of PHQ in dogs was substantially shorter (1.5 hr) so that at 10 h postdose the plasma concentration of PHQ was below 1 ng/mL. As a consequence of this difference in elimination rates, the PHQ AUC in sheep was ~ 5 times greater than in dogs (Table 3 ). In sheep, the PHQ AUC accounted for roughly half of total drug-related material (DRM) AUC whereas in dogs it accounted only for ~ 10 % of total DRM AUC chiefly due to a longer DRM elimination half-life (23 hr) compared to that of PHQ.
This article has not been copyedited and formatted. The final version may differ from this version. Excretion. After oral administration of [ 3 H]PHQ to sheep, dogs and gerbils (0.5, 0.5 and 20 mg/kg, respectively) > 80 % of the radioactivity was recovered in feces and urine after a 72-96 hr collection period (Table 4) . In all three species more than two thirds of the administered dose was recovered in the feces. In sheep, after 24 hr, roughly 50 % of the dose was in the GI tract (Table 5) Unchanged PHQ accounted for < 10 % of total radioactivity in sheep and gerbil feces.
No PHQ could be detected in dog feces. M14, the major metabolite detected in sheep and gerbil feces had a protonated molecular ion at m/z 476 consistent with dehydration of PHQ. The exact position of the double bond could not be determined but was tentatively assigned as endocyclic (Figure 4) . Previous unpublished studies in our laboratories have shown that dehydration at the pyrrolidine moiety resulted in a loss in activity in vitro. Other metabolites in sheep and gerbil feces included M3, M4 and M5.
Interestingly, the cyanide adducts M6 and M8 identified in microsomal incubations were also observed in gerbil feces. Similar to that observed in liver microsomes incubations, the metabolite profile in dog feces was markedly different from those obtained from sheep and gerbils, and M1 and M2 were the main metabolites excreted in dog feces. dose varied from ~350 ng eq./g in the reticulum to 8,150 ng eq./g in the colon (Table 6 ).
At this time point, the total concentration of DRM in plasma was only ~ 20 ng eq./mL (Figure 6 ). At 48 hr post dose, the concentration of DRM in the GI tract varied from 69 ng eq./g in the rumen to 1,220 ng eq./g in the colon while the DRM in plasma decayed to ~ 7 ng eq./mL. Metabolite profiling of the GI tract content at 24 hr post dose indicated that PHQ was the main component of DRM in the four chambers of the sheep stomach.
A small amount (~8%) of the cyano derivative, M6, was detected in the rumen. 
Discussion
The metabolism of paraherquamide in sheep, dogs and gerbils in vivo and in vitro is extensive but is almost exclusively limited to the pyrrolidine and dioxepene groups.
Metabolism and ultimate loss of the dioxepene moiety is most effective in dog liver microsomes preparations and also constituted the major route of metabolism in that species in vivo. A likely mechanism for M1 formation is presented in Figure 10 .
Epoxidation of the isoprenoid double bond followed by hydrolysis leads to formation of a cyclic hemiacetal in equilibrium with its ring-opened isomeric α-hydroxy aldehyde.
The oxindolyl catechol M1 being a good leaving group can be displaced by a retroMichael reaction. Interestingly, in vivo in the dog, the α-hydroxy aldehyde intermediate is oxidized to the acid M17 that is further conjugated with serine to yield M20.
Conjugation with serine is, apparently, a relatively rare event (Reif and Sinsheimer, 1975) probably because serine is a poor substrate for acyl CoA:amino acid N-acyl transferases (van der Westhuizen, et al., 2000) . Metabolism of the pyrrolidone moiety of PHQ is most likely initiated by oxidation of the methylene α to the nitrogen ( Figure   11 ). The intermediate carbinolamine undergoes further oxidation to M5 or two successive dehydration steps leading to the formation of M3. Alternatively it appears that it is also converted to an iminium ion which is trapped by cyanide to form the stereoisomeric cyano conjugates M6 and M8 (Figure 11 ). The identification of these two metabolites in microsomal incubations from all species was intriguing since cyanide was not added to the incubation mixtures. Incorporation of C-13 cyanide into M6 and M8 when the reaction was carried out in the presence of 1% CH 3 13 CN indicated that cyanide was produced from microsomal metabolism of acetonitrile (Freeman and Hayes, 1988) . From the kinetics of this reaction, it is expected that the levels of cyanide could This article has not been copyedited and formatted. The final version may differ from this version. reach up to 250 µM at 60 min and therefore reach sufficient levels to trap any iminium ions formed from PHQ. Surprisingly, M6 and M8 were also observed in vivo in gerbil excreta and blood but not in sheep or dogs. This species difference might due to differences in the cyanogenic glycosides content of their respective diets. In vivo, PHQ undergoes significant dehydration to M14 in the gastro-intestinal tract of sheep which appears to occur primarily in cecum, likely due to the activity of the resident micro-flora (Table 6 ). The same metabolic fate of PHQ is also observed in gerbils where M14 was the major constituent in feces. In both species, M14 was also observed in plasma,
suggesting that it might also be absorbed, albeit to a small extent.
The pharmacodynamic action of anthelmintic agents is a complex phenomenon due in large part to the broad range of compartments in which these parasite reside and a lack of understanding of how parasites acquire the active drug (Geary, et al., 1999) . It is nevertheless accepted that in order to achieve their effects these agents must reach high enough concentrations in all compartments, and plasma concentrations, by themselves, are not necessarily sufficient to assess bioavailability of drug to parasitic nematodes.
With the exception of O. columbianum, PHQ is effective against most common sheep GI parasites after a single oral dose of 0.25 mg/kg. At this dose, plasma levels of PHQ rapidly reached a maximum plasma concentration of ~ 40 ng/mL. The elimination rate was such that by 24 hr the PHQ concentration was ~8 ng/mL and below 1 ng/mL at 72 hr ( Figure 6 ). Although circulating metabolites of PHQ that retained some in vitro activity were observed in sheep plasma, by 48 hr their combined levels were already below 10 ng/mL. These concentrations are well below those required to effectively reduce larval motility of H. contortus, T. colubriformis and O. circumcinta in vitro (Gill and Lacey, 1993) suggesting that exposure to active components in the GI tract compartments is This article has not been copyedited and formatted. The final version may differ from this version. responsible for the activity of PHQ in sheep. At 24 hr post-dose, PHQ was the major DRM in the abomasum, the site of residence of H contortus and O. circumcinta and its concentration was roughly 700 ng/mL (Table 6) . By 42 hr the concentration of PHQ had fallen to ~100 ng/mL. It is anticipated that the concentrations of PHQ in the abomasum at earlier time points were significantly above 700 ng/mL and therefore the concentrations of PHQ until 48 hr post-dose would have been sufficient to reduce the motility of these nematodes and cause them to be flushed out of the stomach. PHQ was somewhat less effective against O. columbianum, a parasite resident in the large intestine of sheep. In agreement with this observation, we have found that PHQ undergoes metabolism in the cecum to a dehydrated product that was shown to have much less activity in vitro so that the concentration of active components in the large intestine is much reduced, necessitating higher effective dose of PHQ to eliminate O.
columbianum from the large intestine.
The absorption of PHQ in dogs was rapid and plasma levels reached a maximum concentration at 30 min (Table 3, Figure 6 ). Contrary to was observed in sheep, PHQ is subsequently rapidly eliminated from plasma. The absence of PHQ in feces and urine indicated that, in dogs, PHQ is eliminated exclusively by metabolism. A sulfate conjugate of M1, M21, was identified as the major circulating metabolite in dog plasma.
M21 was also the major PHQ-related component in dog urine indicating that its major route of clearance was renal extraction. Although M21 was not tested for activity against H. contortus, it is most likely inactive since the benzodioxepene group is required for activity. PHQ would therefore be the major pharmacologically active dogs dosed. These signs, which abated rapidly (by 24 hr post-dose the animals had fully recovered), are in agreement with the previously reported toxicological effects of PHQ in dogs (Shoop, et al., 1991; Shoop, et al., 1992a) and are consistent with ineffective cholinergic muscular transmission. The mode of action of PHQ and related analogs is believed to occur via nicotinic cholinergic antagonism (Qian, et al., 2006; Zinser, et al., 2002) and, taken together, these observations strongly suggest that the adverse effects observed in dogs are mechanism-based and largely due to the parent PHQ. The majority of the administered dose in dogs was eliminated in the feces as metabolites lacking an intact benzodioxepene group and none of these metabolites would be expected to have significant nematodicidal activity. The lack of efficacy of PHQ in dogs can therefore be rationalized by its rapid and extensive absorption and by an equally rapid conversion to inactive metabolites so that gastro-intestinal parasites are only in short and insufficient contact with active drug.
In summary, the data presented herein indicate that the wide differences observed in the nematodicidal efficacy of PHQ in sheep, gerbils and dogs, can largely be to differences in metabolism in these species.
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